And I definitely do not have a desire to drink now
Phase 2 body composition data from the Lancet Diabetes and Endocrinology substudy showed retatrutide achieving fat mass reductions of 15.2% at the 4mg dose, 26.1% at 8mg, and 23.2% at 12mg, while the proportion of lean mass loss relative to total weight loss remained comparable to other GLP-1 compounds
These figures havent been established in human trials, and long-term human safety data doesnt exist
Complete a Proper Health Screening A reputable provider will ask about your medical history, current medications, allergies, pregnancy status, and the specific health goals you want to address
Semaglutide works by targeting the brains hunger-regulating centers , reducing appetite and caloric intake naturally